Oramed Pharmaceuticals Ownership | Who Owns Oramed Pharmaceuticals?
Oramed Pharmaceuticals Ownership Summary
Oramed Pharmaceuticals is owned by 17.33% institutional investors, 13.56% insiders, and 69.11% retail investors. Bml capital management is the largest institutional shareholder, holding 7.59% of ORMP shares. iShares Micro-Cap ETF is the top mutual fund, with 0.19% of its assets in Oramed Pharmaceuticals shares.
ORMP Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Oramed Pharmaceuticals | 17.33% | 13.56% | 69.11% |
| Sector | Healthcare Stocks | 42.54% | 10.83% | 46.63% |
| Industry | Biotech Stocks | 45.22% | 10.75% | 44.04% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Bml capital management | 3.17M | 7.59% | $8.36M |
| Murchinson | 1.75M | 4.20% | $4.62M |
| Boothbay fund management | 845.39K | 2.03% | $2.23M |
| Rathbones group | 233.02K | 0.56% | $615.17M |
| Bank of america corp /de/ | 173.24K | 0.43% | $445.23K |
| Renaissance | 148.90K | 0.36% | $393.10K |
| Dimensional fund advisors lp | 147.49K | 0.35% | $389.37K |
| Wells fargo & company/mn | 130.09K | 0.31% | $343.43K |
| Blackrock funding, inc. /de | 109.73K | 0.26% | $289.70K |
| Susquehanna group, llp | 91.03K | 0.22% | $220.28K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Bml capital management | 3.17M | 7.66% | $8.36M |
| Murchinson | 1.75M | 0.59% | $4.62M |
| Boothbay fund management | 845.39K | 0.03% | $2.23M |
| Sage capital management | 16.75K | 0.02% | $44.22K |
| Glass jacobson investment advisors | 10.54K | 0.01% | $27.83K |
| Rbf capital | 42.95K | 0.01% | $113.38K |
| Xtx topco | 23.89K | 0.00% | $63.06K |
| N.e.w. advisory services | 12.36K | 0.00% | $29.91K |
| Rathbones group | 233.02K | 0.00% | $615.17M |
| Close asset management | 11.68K | 0.00% | $31.00K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Wells fargo & company/mn | 130.09K | 0.00% | 109.10K |
| Bml capital management | 3.17M | 7.66% | 83.98K |
| Blackrock funding, inc. /de | 109.73K | - | 24.16K |
| Xtx topco | 23.89K | 0.00% | 23.89K |
| Jane street group | 59.66K | - | 17.29K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Two sigma advisers, lp | - | - | -213.00K |
| Bank of america corp /de/ | 173.24K | - | -113.81K |
| Peapod lane capital | - | - | -84.78K |
| State street | - | - | -66.45K |
| Two sigma investments, lp | - | - | -64.42K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Xtx topco | 23.89K | 0.00% | 23.89K | $63.06K |
| Fmr | 500.00 | - | 500.00 | $1.32K |
| Allworth financial lp | 300.00 | - | 300.00 | $675.00 |
| Russell investments group | 250.00 | - | 250.00 | $643.00 |
| Jpmorgan chase | 170.00 | - | 170.00 | $449.00 |
Sold Out
| Holder | Change |
|---|---|
| Innealta capital | -13.00 |
| Mather group, llc. | -100.00 |
| Global retirement partners | -100.00 |
| Qube research | -107.00 |
| Beacon capital management | -219.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 44 | -4.35% | 7,236,076 | 1.46% | 17 | 5.70% | 15 | 50.00% | 8 | -46.67% |
| Jun 30, 2025 | 48 | -11.11% | 7,251,754 | -6.69% | 17 | 4.91% | 11 | -42.11% | 15 | -16.67% |
| Mar 31, 2025 | 54 | -10.00% | 7,772,787 | 1.30% | 19 | 5.40% | 21 | -8.70% | 16 | -5.88% |
| Dec 31, 2024 | 23 | -59.65% | 3,266,676 | -53.06% | 7 | 2.70% | 13 | -40.91% | 2 | -85.71% |
| Sep 30, 2024 | 56 | -3.45% | 6,959,416 | 17.28% | 17 | 7.99% | 22 | - | 14 | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| iShares Micro-Cap ETF | 77.93K | 0.19% | - |
| SPDR® Portfolio Developed Wld ex-US ETF | 56.82K | 0.14% | - |
| RBC Microcap Value I | 45.30K | 0.11% | -40.00K |
| Dimensional US Core Equity 2 ETF | 36.54K | 0.09% | - |
| MTF TR TA-Growth | 29.23K | 0.07% | -1.13K |
| I.B.I 70/30 | 26.00K | 0.06% | - |
| Fidelity Nasdaq Composite Index | 24.28K | 0.06% | - |
| Dimensional US Targeted Value ETF | 24.09K | 0.06% | - |
| DFA US Core Equity 2 I | 23.35K | 0.06% | - |
| Avantis US Small Cap Equity ETF | 15.44K | 0.04% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Apr 03, 2023 | Mayer Arie | - | Buy | $11.12K |
| Apr 04, 2023 | Mayer Arie | - | Buy | $8.40K |
| Mar 16, 2023 | KIDRON NADAV | President and CEO | Buy | $53.01K |
| Mar 14, 2023 | KIDRON NADAV | President and CEO | Buy | $201.00K |
| Mar 14, 2023 | Kidron Miriam | Chief Scientific Officer | Sell | $201.00K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q1 | - | - |
| 2024 Q4 | - | - |
| 2024 Q2 | - | - |
| 2024 Q1 | - | - |
| 2023 Q2 | 2 | - |
ORMP Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools